Compatibility Of Vancomycin And Oxacillin During Simulated Y-Site Delivery, 2015 Butler University
Compatibility Of Vancomycin And Oxacillin During Simulated Y-Site Delivery, Hilary Teibel, Chad Knoderer, Kristen Nichols
Kristen R. Nichols
Background: Vancomycin and oxacillin may be used together as empiric coverage in patients with proven or suspected Staphylococcus aureus infections. Though vancomycin hydrochloride 20 mg/mL and oxacillin sodium 160 mg/mL are reported to be compatible via Y-site delivery, Y-site compatibility of commonly used concentrations, vancomycin 10 mg/mL and oxacillin 20 mg/mL, has not yet been reported. Objective: To determine the Y-site compatibility of vancomycin 10 mg/mL and oxacillin 20 mg/mL. Methods: One vancomycin hydrochloride 1 g vial was reconstituted with 10 mL sterile water for injection (SWFI) and diluted with 90 mL 5% dextrose in water (D5W) in an evacuated …
Optimized Antimicrobial Dosing Strategies: A Survey Of Pediatric Hospitals, 2015 Butler University
Optimized Antimicrobial Dosing Strategies: A Survey Of Pediatric Hospitals, Chad A. Knoderer, Kristen R. Nichols, Elaine G. Cox
Kristen R. Nichols
Background Extended-interval aminoglycoside (EIAG) and extended- and continuous-infusion β-lactam (EIBL and CIBL) dosing strategies are increasingly used in adults, but pediatric literature is limited. Objective The objective of this study was to describe the use of EIAG, EIBL, and CIBL dosing in pediatric hospitals in the USA. Study Design, Setting, and Participants A national survey of children’s hospitals was conducted. A single practitioner from each target hospital was identified through the Children’s Hospital Association. Practice-based survey questions identified whether hospitals utilize EIAG, EIBL, and CIBL dosing. Main Outcome Measure The main outcome measure was the percentage utilization of the dosing …
Physical, Thermal And Spectral Properties Of Biofield Treated 1,2,3-Trimethoxybenzene, 2015 Trivedi Global Inc.
Physical, Thermal And Spectral Properties Of Biofield Treated 1,2,3-Trimethoxybenzene, Mahendra Kumar Trivedi, Rama Mohan Tallapragada, Alice Branton, Dahryn Trivedi, Gopal Nayak, Rakesh K. Mishra, Snehasis Jana
Mahendra Kumar Trivedi
Physicochemical And Spectroscopic Characterization Of Biofield Treated Butylated Hydroxytoluene, 2015 Trivedi Global Inc.
Physicochemical And Spectroscopic Characterization Of Biofield Treated Butylated Hydroxytoluene, Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Ragini Singh, Snehasis Jana
Mahendra Kumar Trivedi
The Flaws And Human Harms Of Animal Experimentation, 2015 Oxford Centre for Animal Ethics
The Flaws And Human Harms Of Animal Experimentation, Aysha Akhtar
Experimentation Collection
Nonhuman animal (“animal”) experimentation is typically defended by arguments that it is reliable, that animals provide sufficiently good models of human biology and diseases to yield relevant information, and that, consequently, its use provides major human health benefits. I demonstrate that a growing body of scientific literature critically assessing the validity of animal experimentation generally (and animal modeling specifically) raises important concerns about its reliability and predictive value for human outcomes and for understanding human physiology. The unreliability of animal experimentation across a wide range of areas undermines scientific arguments in favor of the practice. Additionally, I show how animal …
Pharmdigest Volume 2, Issue 1, 2015 Philadelphia College of Osteopathic Medicine
Pharmdigest Volume 2, Issue 1, Philadelphia College Of Osteopathic Medicine, School Of Pharmacy
PharmDigest
This issue of the Pharmacy Student Council newsletter includes the following articles:
- Greetings
- What is Your King Piece?
- Economics in Pharmacy
- Community Pharmacy
- The Daily Dose: APhA in D.C.
- GSHP Summer Meeting
- Tips for Students
- Pharmacy goes Greek
- A Trip to Philly
- Institutional Pharmacy
- Message to the P1s
The Medicine Shoppe V. Loretta Lynch: Pharmacists’ Corresponding Responsibility With Physicians Under Dea Interpretation Of The “Legitimate Medical Purpose” Standard, 2015 SelectedWorks
The Medicine Shoppe V. Loretta Lynch: Pharmacists’ Corresponding Responsibility With Physicians Under Dea Interpretation Of The “Legitimate Medical Purpose” Standard, Jeffrey C. Grass Jd, Ms, Aclm
Jeffrey C. Grass JD, MS, ACLM
The Medicine Shoppe v. Loretta Lynch et al. 14-1223 will assist pharmacists and pharmacy owners in understanding their duties “corresponding responsibility to assure that its prescriptions for controlled substances are issued for a legitimate medical purpose” and “in the practitioner's usual course of professional practice.” In the meantime, pharmacists need to know that they are not immune from administrative, regulatory or criminal prosecution under the CSA solely due to their status. Rather, they are expected to dispense drugs for the bona fide treatment of a patient's disease. Under this regime, he or she must exercise sound professional judgment when evaluating …
Selective C1 Lesioning Slightly Decreases Angiotensin Ii Type I Receptor Expression In The Rat Rostral Ventrolateral Medulla (Rvlm)., 2015 Mississippi College; University of Mississippi
Selective C1 Lesioning Slightly Decreases Angiotensin Ii Type I Receptor Expression In The Rat Rostral Ventrolateral Medulla (Rvlm)., Erick A Bourassa, Kristen A Stedenfeld, Alan F Sved, Robert Charles Speth
Faculty Articles
Cardiovascular homeostasis is regulated in large part by the rostral ventrolateral medulla (RVLM) in mammals. Projections from the RVLM to the intermediolateral column of the thoracolumbar spinal cord innervate preganglionic neurons of the sympathetic nervous system causing elevation of blood pressure and heart rate. A large proportion, but not all, of the neurons in the RVLM contain the enzymes necessary for the production of epinephrine and are identified as the C1 cell group. Angiotensin II (Ang II) activates the RVLM acting upon AT1 receptors. To assess the proportion of AT1 receptors that are located on C1 neurons in the rat …
Nsu Sharks Rx - Fall 2015, 2015 Nova Southeastern University
A Solid Dispersion Based On Milk-Micelle As A Drug-Carrier For The Enhancement Of The Aqueous Solubility Of Ritonavir, 2015 R.T.M. Nagpur University
A Solid Dispersion Based On Milk-Micelle As A Drug-Carrier For The Enhancement Of The Aqueous Solubility Of Ritonavir, Pradip Dhore, Suprit Saoji, Nishikant Raut, M. Bernardez, Rahul V. Haware, Vivek S. Dave
Pharmacy Faculty/Staff Publications
The goal of present investigation was to evaluate the feasibility of formulating a solid-dispersion using milk-micelles as drug-carriers, to enhance the aqueous solubility of ritonavir.
Monitoring Of Outpatient Parenteral Antimicrobial Therapy (Opat) And Implementation Of Clinical Pharmacy Services At A Community Hospital Infusion Unit, 2015 HSHS St. John's Hospital
Monitoring Of Outpatient Parenteral Antimicrobial Therapy (Opat) And Implementation Of Clinical Pharmacy Services At A Community Hospital Infusion Unit, Punit J. Shah, Scott Bergman, Donald Graham, Stephanie Glenn
SIUE Faculty Research, Scholarship, and Creative Activity
Background: In 2004, the Infectious Diseases Society of America (IDSA) published monitoring guidelines for outpatient parenteral antimicrobial therapy (OPAT), but no assessment of their utilization has been reported. We evaluated adherence to these recommendations by physicians at infusion centers and then piloted a program of supervision of monitoring by pharmacists.
Methods: Phase I: We performed a retrospective case-control study of patients who received OPAT over one year at two hospital infusion centers. Controls were patients treated by an infectious diseases (ID) physician, and cases were those without an ID physician. Patients were excluded if they received fewer than …
Copd: Optimizing Treatment, 2015 St. John Fisher University
Copd: Optimizing Treatment, Nabila Ahmed-Sarwar, Deirdre P. Pierce, David C. Holub
Pharmacy Faculty/Staff Publications
A guideline update and an expanded armamentarium have many physicians wondering how best to treat patients with COPD. Chronic obstructive pulmonary disease (COPD) carries a high disease burden. In 2012, it was the 4th leading cause of death worldwide.1,2 In 2015, the World Health Organization updated its Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines, classifying patients with COPD based on disease burden as determined by symptoms, airflow obstruction, and exacerbation history.3 These revisions, coupled with expanded therapeutic options within established classes of medications and new combination drugs to treat COPD (TABLE 1),3-6 have led to questions about interclass …
Formulation Of A Drug-Phospholipid Complex (Naturosome) To Enhance The Aqueous Solubility Of Standardized Extract Of Centella Asiastica (Sce), 2015 R.T.M. Nagpur University
Formulation Of A Drug-Phospholipid Complex (Naturosome) To Enhance The Aqueous Solubility Of Standardized Extract Of Centella Asiastica (Sce), Suprit Saoji, Nishikant Raut, Pradip Dhore, M. Bernardez, Rahul V. Haware, Vivek S. Dave
Pharmacy Faculty/Staff Publications
Purpose:
To evaluate the enhancement of aqueous solubility of standardized extract of Centella asiastica, a natural drug with known anti- Alzheimer’s activity, by formulating its complex (Naturosome) with a phospholipid - Phospholipon® 90H.
The Enhancement Of The Aqueous Solubility Of Ritonavir Via Formulation Of A Drug-Phospholipid Complex, 2015 R.T.M. Nagpur University
The Enhancement Of The Aqueous Solubility Of Ritonavir Via Formulation Of A Drug-Phospholipid Complex, Suprit Saoji, Nishikant Raut, Pradip Dhore, R. G. Diware, M. Bernardez, Rahul V. Haware, Vivek S. Dave
Pharmacy Faculty/Staff Publications
Objective: To evaluate the enhancement of aqueous solubility of a poorly water soluble drug ritonavir by forming its complex with a phospholipid (Phospholipon®90H).
Silver Nanoparticles Induce Tight Junction Disruption And Astrocyte Neurotoxicity In A Rat Blood-Brain Barrier Primary Triple Coculture Model, 2015 National Institutes for Food and Drug Control, China
Silver Nanoparticles Induce Tight Junction Disruption And Astrocyte Neurotoxicity In A Rat Blood-Brain Barrier Primary Triple Coculture Model, Liming Xu, Mo Dan, Anliang Shao, Xiang Cheng, Cuiping Zhang, Robert A. Yokel, Taro Takemura, Nobutaka Hanagata, Masami Niwa, Daisuke Watanabe
Pharmaceutical Sciences Faculty Publications
BACKGROUND: Silver nanoparticles (Ag-NPs) can enter the brain and induce neurotoxicity. However, the toxicity of Ag-NPs on the blood-brain barrier (BBB) and the underlying mechanism(s) of action on the BBB and the brain are not well understood.
METHOD: To investigate Ag-NP suspension (Ag-NPS)-induced toxicity, a triple coculture BBB model of rat brain microvascular endothelial cells, pericytes, and astrocytes was established. The BBB permeability and tight junction protein expression in response to Ag-NPS, NP-released Ag ions, and polystyrene-NP exposure were investigated. Ultrastructural changes of the microvascular endothelial cells, pericytes, and astrocytes were observed using transmission electron microscopy (TEM). Global gene expression …
Physical, Thermal And Spectral Properties Of Biofield Energy Treated 2,4-Dihydroxybenzophenone, 2015 Trivedi Global Inc.
Physical, Thermal And Spectral Properties Of Biofield Energy Treated 2,4-Dihydroxybenzophenone, Mahendra Kumar Trivedi, Rama Mohan Tallapragada, Alice Branton, Dahryn Trivedi, Gopal Nayak, Rakesh K. Mishra, Snehasis Jana
Mahendra Kumar Trivedi
Investigation Of Isotopic Abundance Ratio Of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry, 2015 Trivedi Global Inc.
Investigation Of Isotopic Abundance Ratio Of Biofield Treated Phenol Derivatives Using Gas Chromatography-Mass Spectrometry, Mahendra Kumar Trivedi, Alice Branton, Dahryn Trivedi, Gopal Nayak, Gunin Saikia, Snehasis Jana
Mahendra Kumar Trivedi
Compatibility Of Vancomycin And Oxacillin During Simulated Y-Site Delivery, 2015 Butler University
Compatibility Of Vancomycin And Oxacillin During Simulated Y-Site Delivery, Chad A. Knoderer, Hilary M. Teibel, Kristen R. Nichols
Scholarship and Professional Work – COPHS
Background: Vancomycin and oxacillin may be used together as empiric coverage in patients with proven or suspected Staphylococcus aureus infections. Though vancomycin hydrochloride 20 mg/mL and oxacillin sodium 160 mg/mL are reported to be compatible via Y-site delivery, Y-site compatibility of commonly used concentrations, vancomycin 10 mg/mL and oxacillin 20 mg/mL, has not yet been reported. Objective: To determine the Y-site compatibility of vancomycin 10 mg/mL and oxacillin 20 mg/mL. Methods: One vancomycin hydrochloride 1 g vial was reconstituted with 10 mL sterile water for injection (SWFI) and diluted with 90 mL 5% dextrose in water (D5W) …
Stilbene Analogs And Methods Of Treating Cancer, 2015 University of Kentucky
Stilbene Analogs And Methods Of Treating Cancer, David Watt, Chunming Liu, Vitaliy M. Sviripa, Wen Zhang
Pharmaceutical Sciences Faculty Patents
Stilbene analogs and pharmaceutical compositions that are useful for the treatment of various cancers, including without limitation, colorectal cancer (CRC) and breast cancer are disclosed. The halogenated stilbene analogs include nitrogen heteroaryl groups and/or amino groups on the stilbene ring.
Ebola Virus Infection: Overview And Update On Prevention And Treatment, 2015 Universitat de Barcelona
Ebola Virus Infection: Overview And Update On Prevention And Treatment, Miguel J. Martínez, Abdulbaset M. Salim, Juan C. Hurtado, Paul E. Kilgore
Department of Pharmacy Practice
In 2014 and 2015, the largest Ebola virus disease (EVD) outbreak in history affected large populations across West Africa. The goal of this report is to provide an update on the epidemic and review current progress in the development, evaluation and deployment of prevention and treatment strategies for EVD. Relevant information was identified through a comprehensive literature search using Medline, PubMed and CINAHL Complete and using the search terms Ebola, Ebola virus disease, Ebola hemorrhagic fever, West Africa outbreak, Ebola transmission, Ebola symptoms and signs, Ebola diagnosis, Ebola treatment, vaccines for Ebola and clinical trials on Ebola. Through 22 July …